Skip to Content

AHIP Comments on Telemedicine Prescribing of Controlled Substances

Comment Letter

AHIP comments on telemedicine prescribing of controlled substances when the practitioner and the patient haven't had a prior in-person evaluation.

Document Info

Published on Apr 3, 2023

Download and read the full Resource.

Related Issues

Resource Details

AHIP Comments on the proposed rule on Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation, published in the Federal Register on March 1, 2023.


AHIP strongly supports the use of telemedicine and our members are committed to expanding access to virtual care. While we appreciate the Drug Enforcement Administration’s (DEA’s) efforts to balance patient access with patient safety, we are concerned that the proposed rule may erect barriers to further innovation in health care and offer several recommendations for consideration.